GlycoMimetics Inc. (GLYC) had a good day on the market for Friday March 15 as shares jumped 5.95% to close at $12.10. About 778,524 shares traded hands on 1,920 trades for the day, compared with an average daily volume of n/a shares out of a total float of 43.17 million. After opening the trading day at $11.43, shares of GlycoMimetics Inc. stayed within a range of $12.14 to $11.42.
With today’s gains, GlycoMimetics Inc. now has a market cap of $522.34 million. Shares of GlycoMimetics Inc. have been trading within a range of $19.20 and $8.29 over the last year, and it had a 50-day SMA of $n/a and a 200-day SMA of $n/a.
GlycoMimetics Inc is a clinical stage biotechnology company. It is focused on the discovery and development of novel glycomimetic drugs to address unmet medical needs resulting from diseases in which carbohydrate biology plays a key role. Glycomimetics are molecules that mimic the structure of carbohydrates involved in important biological processes. Using expertise in carbohydrate chemistry and knowledge of carbohydrate biology, the company is developing a pipeline of proprietary glycomimetics that may inhibit disease-related functions of carbohydrates, such as the roles it plays in inflammation, cancer, and infection.
GlycoMimetics Inc. is based out of Rockville, MD and has some 40 employees. Its CEO is Rachel K. King.